News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Progenics Pharmaceuticals, Inc. (PGNX) Cuts 26% of Jobs, Replaces CFO



9/21/2012 8:15:38 AM

Progenics Pharmaceuticals Inc cut 26 percent of its workforce and replaced its chief financial officer to focus on its cancer programs after U.S. health regulators did not approve its constipation drug for use in a wider population. Chief Financial Officer Robert McKinney and Senior Vice President Benedict Osorio will step down on September 30. Treasurer Angelo Lovallo will become principal financial officer and principal accounting officer, Progenics said. Progenics's only marketable injection, Relistor, treats opioid-induced constipation in patients with advanced illnesses.

Read at Reuters
Read at RTT News
Read at CBS News
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES